Green synthesis for the treatment of type-II diabetes
Type-II diabetes mellitus (T2DM) is a serious threat to human life as till the year 2019, approximately 463 million individuals of age between 20-79 years are suffering with diabetes and it will rise to 700 million by the year 2045. For the testing and diagnosis of diabetes, The WHO and the ADA are...
Main Authors: | Pavani Krishna Kumara Karitla, Kaur Gurmeet |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2023/67/e3sconf_icmpc2023_01279.pdf |
Similar Items
-
Environment friendly synthesis and characterization of manganese(II) Imidazolate framework
by: Singh Shristy, et al.
Published: (2024-01-01) -
METABOLIC SURGERY IN TREATMENT OF DIABETES MELLITUS OF TYPE II
by: V. M. Sedov, et al.
Published: (2018-01-01) -
Influence of Social Support on Treatment of Type II Diabetes in Yazd
by: A Zare Shahabadi, et al.
Published: (2010-08-01) -
The Potential of Neoagaro-Oligosaccharides as a Treatment of Type II Diabetes in Mice
by: Fudi Lin, et al.
Published: (2019-09-01) -
Physical activity in type II diabetes
by: Martyna Kępczyk, et al.
Published: (2024-01-01)